ASXC - Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program | Benzinga
RESEARCH TRIANGLE PARK, N.C., June 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
"We are excited to collaborate with the St. Marianna University School of Medicine Yokohama City Seibu Hospital to bring our Senhance Surgical System to this innovative institution," said Anthony Fernando, President and CEO of Asensus Surgical. "Powered by our Intelligent Surgical Unit™ with Augmented Intelligence capabilities, this system represents a leap forward, offering surgeons unparalleled real-time insights that leverage the collective expertise from procedures performed around the world."
"The Senhance System's ability to facilitate a seamless integration of human skill with clinical intelligence will be tremendously valuable for our surgeons," said Dr. Masanori Naito, M.D.,Ph.D. Hospital Vice Director, Head of Gastroenterological & General Surgery. "Our hospital seeks to blend scientific excellence with compassionate, patient-centered care. We look forward to harnessing its capabilities in our GI/General Surgery & Urology specialties as we continue pushing the boundaries of medical innovation."
The Senhance Surgical System is designed to increase surgeon control and reduce variability through Augmented Intelligence and deep learning capabilities.
About St. Marianna University School of Medicine Yokohama City Seibu Hospital
Our university was founded in 1971 by the devout Catholic Dr. Kamon Akashi. Then-Pope Paul VI ...